IP Library Granted Patent US 8,944,049
Granted Patent B2
US 8,944,049 · App. 14/107,554 · Granted Feb 3, 2015

Systems and devices for generating nitric oxide

Inventors: David H. Fine (Cocoa Beach, FL); Bryan Johnson (Orlando, FL); Gregory Vasquez (Cocoa, FL)
Assignee: GENO LLC
A61M16/12A61M16/10A61M16/16C01B21/24A61M16/0666A61M16/104A61M16/1075A61M2202/0275A61M16/105
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,944,049
App. No.
14/107,554
Granted
Feb 3, 2015
Kind
B2
Abstract

Various systems and devices for generating nitric oxide are disclosed herein. According to one embodiment, the device includes a body having an inlet, an outlet, and a porous solid matrix positioned with the body. The porous solid matrix is coated with an aqueous solution of an antioxidant, wherein the inlet is configured to receive a gas flow and fluidly communicate the gas flow to the outlet through the solid matrix to convert nitrogen dioxide in the gas flow into nitric oxide. The porous solid matrix allows the device to be used in any orientation. Additionally, the porous solid matrix provides a rigid structure suitable to withstand vibrations and abuse without compromising device functionality.

Claims (21)

1. A device for generating nitric oxide from nitrogen dioxide, comprising:

a receptacle including an inlet, an outlet and a diverter,

a porous solid matrix including an antioxidant positioned within the receptacle, and

a space between the receptacle and the porous solid matrix,

wherein the space has a width, which is the distance between an outer surface of the porous solid matrix to the receptacle, and the width of the space is variable along a length of the receptacle, and

wherein the inlet is configured to receive a gas flow, the diverter directs the gas flow to the space between the receptacle and the porous solid matrix, and the gas flow is fluidly communicated to the outlet through the porous solid matrix to convert nitrogen dioxide in the gas flow into nitric oxide.

2. The device of claim 1 , wherein the width of the space decreases along a portion of the length of the receptacle.

3. The device of claim 1 , wherein the width of the space increases along a portion of the length of the receptacle.

4. The device of claim 1 , wherein the width of the space increases along a portion of the length of the receptacle extending from the inlet to approximately the midpoint of the receptacle, and the width of the space decreases along a portion of the length of the receptacle extending from approximately the midpoint of the receptacle to the outlet.

5. A system for delivering nitric oxide to a patient, comprising:

a gas source of nitrogen dioxide, dinitrogen tetraoxide, or nitric oxide;

a first device having a receptacle including an inlet, an outlet and a diverter, a porous solid matrix including an antioxidant positioned within the receptacle, and a space between the receptacle and the porous solid matrix, wherein the space has a width, which is the distance between an outer surface of the porous solid matrix to the receptacle, and the width of the space is variable along a length of the receptacle, and wherein the inlet is configured to receive a gas flow, the diverter directs the gas flow to the space between the receptacle and the porous solid matrix, and the gas flow is fluidly communicated to the outlet through the porous solid matrix to convert nitrogen dioxide in the gas flow into nitric oxide; and

a patient interface coupled to the outlet of the first device, the patient interface delivering nitric oxide to the patient.

6. The system of claim 5 , further comprising a humidifier positioned between the gas source and the first device.

7. The system of claim 6 , wherein the humidifier is integral with the first device.

8. The system of claim 5 , further comprising a humidifier positioned prior to the patient interface.

9. The system of claim 6 , wherein the humidifier has a temperature between 18° C. and 23° C.

10. The system of claim 8 , wherein the humidifier has a temperature of between 32° C. and 37° C.

11. The system of claim 6 , further comprising:

a second humidifier positioned after the first device; and

a second device positioned after a second humidifier, the second device having a receptacle including an inlet, an outlet and a diverter, a porous solid matrix including an antioxidant positioned within the receptacle, and a space between the receptacle and the porous solid matrix, wherein the space has a width, which is the distance between an outer surface of the porous solid matrix to the receptacle, and the width of the space is variable along a length of the receptacle, and wherein the inlet is configured to receive a gas flow, the diverter directs the gas flow to the space between the receptacle and the porous solid matrix, and the gas flow is fluidly communicated to the outlet through the porous solid matrix to convert nitrogen dioxide in the gas flow into nitric oxide.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Mar 18, 2026
From: HORIZON TECHNOLOGY FINANCE CORPORATION
To: VERO BIOTECH INC.
Reel/Frame 075308/0198 →
SECURITY INTEREST Recorded Mar 16, 2026
From: VERO BIOTECH INC.
To: SYMBIOTIC CAPITAL AGENCY LLC, AS COLLATERAL AGENT
Reel/Frame 075117/0935 →
TERMINATION AND RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 3, 2024
From: RUNWAY GROWTH FINANCE CORP (F/K/A RUNWAY GROWTH CREDIT FUND INC.)
To: VERO BIOTECH INC. (F/K/A VERO BIOTECH LLC)
Reel/Frame 066186/0611 →
SECURITY INTEREST Recorded Jan 3, 2024
From: VERO BIOTECH INC.
To: HORIZON TECHNOLOGY FINANCE CORPORATION
Reel/Frame 066187/0865 →
CHANGE OF NAME Recorded Feb 14, 2022
From: VERO BIOTECH LLC
To: VERO BIOTECH INC.
Reel/Frame 059085/0418 →
SECURITY INTEREST Recorded Dec 29, 2020
From: VERO BIOTECH LLC
To: RUNWAY GROWTH CREDIT FUND INC.
Reel/Frame 054866/0589 →
CHANGE OF NAME Recorded Jun 6, 2018
From: GENO LLC
To: VERO BIOTECH LLC
Reel/Frame 046304/0855 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2013
From: FINE, DAVID H.; JOHNSON, BRYAN; VASQUEZ, GREGORY
To: GENO LLC
Reel/Frame 031817/0548 →
Continuity (3)
Continuation 12541137 · Aug 13, 2009
Provisional Application 61090614 · Aug 21, 2008
Related Publication 20140102447A1 · Apr 17, 2014